Free shipping on all orders over $ 500

LY2874455

Cat. No. M3617

All AbMole products are for research use only, cannot be used for human consumption.

LY2874455 Structure
Size Price Availability Quantity
5mg USD 165  USD165 In stock
10mg USD 250  USD250 In stock
50mg USD 750  USD750 In stock
100mg USD 980  USD980 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

LY2874455 is a novel and potent FGF/FGFR inhibitor. LY2874455 exhibits a potent activity against FGF/FGFR-mediated signaling in several cancer cell lines. LY2874455 exhibits a 6- to 9-fold in vitro and in vivo selectivity on inhibition of FGF- over VEGF-mediated target signaling in mice. LY2874455 did not show VEGF receptor 2-mediated toxicities such as hypertension at efficacious doses. Currently, this molecule is being evaluated for its potential use in the clinic.

Protocol (for reference only)
Cell Experiment
Cell lines KMS-11, OPM-2, L-363, U266, SNU-16, KATO-III, NUGC-3 and SH-10-TC cells
Preparation method Growing cells (2,000 per well) first in RPMI for 6 hours and treating with LY2874455 at 37 ℃ for 3 days. Staining the cells at 37℃ for 4 hours and then solubilizing at 37℃ for 1 hour. Finally, using a plate reader (Spectra Max Gemini XS) to read the plate at 570 nm.
Concentrations ~1 μM
Incubation time 72 hours
Animal Experiment
Animal models Mice bearing RT-112, OPM-2 (DSMZ), SNU-16, or NCI-H460 xenograft
Formulation 10% Acacia
Dosages 3 mg/kg
Administration p.o.
Chemical Information
Molecular Weight 444.31
Formula C21H19Cl2N5O2
CAS Number 1254473-64-7
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Zhao G, et al. Mol Cancer Ther. A novel, selective inhibitor of fibroblast growth factor receptors that shows a potent broad spectrum of antitumor activity in several tumor xenograft models.

Related FGFR Products
SNIPER(TACC3)-11 

SNIPER(TACC3)-11 is a potent FGFR3-TACC3 degrader.

LY-3076226

LY-3076226 is an antibody drug coupling (ADC) with a cleavable linker targeting FGFR2.

Aprutumab ixadotin

Aprutumab ixadotin is an antibody drug coupling (ADC) with a non-cleavable linker that targets FGFR2.

Gunagratinib

Gunagratinib is an orally active, potent, selective, and irreversible fibroblast growth factor receptor (pan-FGFR) inhibitor for use in cancer research.

SAR-442501

SAR-442501 is a novel anti-FGFR3 monoclonal antibody for studies related to achondroplasia (ACH).

  Catalog
Abmole Inhibitor Catalog




Keywords: LY2874455 supplier, FGFR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.